Author: UoD Web Team
1 min read
Congratulations to Guilherme for successfully defending his PhD thesis viva today!
1 min read
You can view Will’s presentation during the webinar on YouTube or TOCRIS website.
1 min read
Congratulations to Hannah in Dario Alessi’s group for the great job on this study. Well done Andrea for the compound design and synthetic contributions to the project! Read the open access article Title: Design and Characterization of SGK3-PROTAC1, an Isoform…
1 min read
Well done Chiara! Read the full article. Authors: Chiara Maniaci and Alessio Ciulli* Title: Bifunctional chemical probes inducing protein-protein interactions. Abstract Inducing biomolecular interactions with synthetic molecules to impact biological function is a concept of enormous appeal.…
1 min read
University of Dundee and Eisai enter partnership for cancer drug discovery using targeted protein degradation. Read the full press release from Eisai Related links Eisai PR: EISAI ENTERS INTO COLLABORATION RESEARCH AGREEMENT WITH UNIVERSITY OF DUNDEE…
1 min read
Alessio delivers one of the plenary lectures at the XXVI National Meeting in Medicinal Chemistry (NMMC 2019) in Milan, Italy. Read more about conference in the ChemMedChem’s Editorial: “Overview of the XXVI National Meeting in Medicinal Chemistry” by Prof.…
1 min read
Order MZ1 for free today! Related Links University and Boehringer Ingelheim collaborate for free access of PROTAC compound University of Dundee and Boehringer Ingelheim collaborate for free access of PROTAC compound on opnMe.com Drug Discovery Today®…
1 min read
The Group’s mighty team “Focaccia” won the 2019 PiCLS Dodgeball Tournament. Well done team! Congrats to Adam, Alessandra, Conner, Daniela, and Ryan. Good work guys – Graduate students rule!
1 min read
Dundee and Boehringer Ingelheim collaborate on video PR for the launch of PROTAC degraders on BI’s open innovation platform OpnMe Check our OpnMe videos here: 1) MZ1 PROTAC’s Journey to research labs (video) 2) ACBI1 PROTAC’s Journey…
1 min read
Read the article Open Access as SharedIt version Fantastic job Will, Manfred and team! Researchers can now access the SMARCA2/4 degrader ACBI1 for their own research – order the molecule completely free of charge from OpnMe. Related…